Germany’s Merck Agrees To Buy Sigma-Aldrich

Oct. 1, 2014
Germany’s Merck KGaA is purchasing Sigma-Aldrich for $17 billion.

German pharmaceutical company Merck KGaA agreed to purchase life sciences company Sigma-Aldrich for $17 billion, according to The New York Times. Citing Merck, the article described the transaction as a “quantum leap” for the company’s life sciences business. The deal is expected to give Merck greater presence in North America and in Asian markets.

Merck will pay $140 a share in cash to purchase all outstanding shares of Sigma-Aldrich. According to the The New York Times, the deal values Sigma-Allen at approximately $17 billion. The deal is expected to close in the middle of next year.

Read the entire article here.

Sponsored Recommendations

Nominations are open for Chemical Processing's biennial awards. Submit your product innovations in one of 10 categories.